Locomotor Training (Walking Therapy) Post Stroke
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00715299|
Recruitment Status : Completed
First Posted : July 15, 2008
Results First Posted : March 5, 2015
Last Update Posted : March 5, 2015
|Condition or disease||Intervention/treatment||Phase|
|Stroke||Behavioral: locomotor training||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||38 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Mechanisms of Response to Locomotor Training After Stroke|
|Study Start Date :||June 2005|
|Actual Primary Completion Date :||October 2010|
|Actual Study Completion Date :||October 2010|
Locomotor Training Group
persons who have sustained a stroke within greater than 6 months ago and less than 5 years.
Behavioral: locomotor training
Persons will train 3 times a week for 12 weeks. The training sessions will each last about an hour to an hour and a half. Therapists will manipulate the participant's body to generate stepping and walking that is more consistent with normal walking. Someone will manipulate the trunk by standing at the waist and helping with weight shift and proper upper body mechanics. The other two therapists will sit at the legs and bend and extend them as they should in a more normal gait pattern.
- The Primary Outcome Measure Was Pre-treatment to Post-treatment Change in Self-selected Walking Speed. [ Time Frame: Pre and post Treatment ]Walking speed is a continuous measure descriptive of overall ambulatory function. This is easily captured with a pressure-sensitive walkway. Three of the 30 participants who completed the study had incomplete data sets, so outcomes are reported on an n=27.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00715299
|United States, Florida|
|North Florida/South Georgia Veterans Health System|
|Gainesville, Florida, United States, 32608|
|Principal Investigator:||Steve A. Kautz, PhD MS BS||Ralph H. Johnson VA Medical Center, Charleston, SC|